Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by BradlTheGerman

C.PHRM

RE:Why low-cost ketamine is still inaccessible to many...

The article describes very well that ketamine can help in many areas of...

April 24, 2024

C.PHRM

Why low-cost ketamine is still inaccessible to many...

Why low-cost ketamine is still inaccessible to many with severe depression...

April 24, 2024

C.PHRM

13 trading days left !

I very much doubt that there is a leak from the FDA. Fear, doubt, nervousness...

April 11, 2024

C.PHRM

No reason to be nervous !

To be honest, I'm not worried about the fall in prices. It was clear to...

April 10, 2024

C.PHRM

👉👌💪

https://www.google.com/amp/s/simplywall.st/stocks/ca/pharmaceuticals-biotech...

December 31, 2023

T.APLI

ATI -1701

Appili was granted a pre-IND meeting with the FDA to discuss ATI-1701’s...

December 17, 2023

T.APLI

New shareholder.

I have bought my first 75.000 shares over the last two weeks. I am going to...

December 16, 2023

V.SBM

RE:RE:RE:Allergan Clinical trial with TFC-1067??

Yes, a soon product launch - including a milestone payment - is very likely...

August 1, 2023

V.SBM

RE:RE:RE:Management

Every fishing man, hunter or investor understand what patience is. Looks like...

July 13, 2023

V.SBM

RE:😂

You are just an amateur investor, simply an idiot.

July 13, 2023

V.SBM

RE:Management

I have an idea. If you have no patience then sell your shares as soon as...

July 13, 2023

V.SBM

RE:Management

Nothing - I can't see any fraud.

July 13, 2023

V.SBM

RE:RE:RE:RE:SLEEPY HOWARD, GAMECHANGER IS 11.5 CENT STOCK PRICE

Stupid German bla bla bla...sell your shares and get a life.

July 12, 2023

V.SBM

RE:Novartis and the (still?) non-existent SGLT2 inhibitor?!

370 / 3000     ...

June 27, 2023

V.SBM

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1

You can call me the "God of the stock markets", thanks in advance...

June 20, 2023

V.SBM

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Don't waste time with individual license agreements for TFC1

If you can't live with the current situation you should leave the stock...

June 19, 2023

V.BIGG

RE:Bigg Digital Assets loses $750,925 in Q1 Ouff! BIGG go 0.20¢

This news is 8 days old. Do your homework idiot.

June 8, 2023

V.SBM

RE:One week to go!!

And by the way please ask yourself why over 100.000 shares are already sold...

May 31, 2023

V.SBM

RE:One week to go!!

Nothing will happen before or after the BIO presentation. Zero. Wake up Peter...

May 31, 2023

V.BIGG

RE:Wow! ==> BIG NEWS! <== Yessssssss! $$$$$$$$$$

Take a look at PPS. The market is not celebrating the news.

May 16, 2023

1 2 3 4 Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »